Therefore, two possibilities exist; one possibility is the enhanced CD133 originates from contaminated natural CD133+ cells, whereas the other possibility is that these GSCs originate from differentiated cancer cells through dedifferentiation under hypoxic conditions. The gene discussed is PROM1; the disease is cancer.